Antirelapse therapy for visceral leishmaniasis in immunocompetent population and diagnostic dilemmas in therapeutic assessment in India
Visceral leishmaniasis (VL), a severe parasitic infection caused by Leishmania species, presents a significant challenge due to its potential for relapse despite treatment. This review aims to rationalize antirelapse therapies for VL and address diagnostic dilemmas encountered in therapeutic assessm...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-06-01
|
| Series: | Annals of Medical Science and Research |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/amsr.amsr_50_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Visceral leishmaniasis (VL), a severe parasitic infection caused by Leishmania species, presents a significant challenge due to its potential for relapse despite treatment. This review aims to rationalize antirelapse therapies for VL and address diagnostic dilemmas encountered in therapeutic assessment. By evaluating current treatment strategies, examining relapse mechanisms, and highlighting diagnostic challenges, we aim to provide a comprehensive understanding of effective management and assessment of VL relapse. |
|---|---|
| ISSN: | 2949-785X 2949-7868 |